Overview of the 2022 WHO Classification of Paragangliomas and Pheochromocytomas.
Mete O, Asa SL, Gill AJ, Kimura N, de Krijger RR, Tischler A.
Endocr Pathol. 2022 Mar;33(1):90-114. doi: 10.1007/s12022-022-09704-6. Epub 2022 Mar 13.
Origin and initiation mechanisms of neuroblastoma.
Tsubota S, Kadomatsu K.
Cell Tissue Res. 2018 May;372(2):211-221. doi: 10.1007/s00441-018-2796-z. Epub 2018 Feb 14.
Recent advances in the developmental origin of neuroblastoma: an overview.
Ponzoni M, Bachetti T, Corrias MV, Brignole C, Pastorino F, Calarco E, Bensa V, Giusto E, Ceccherini I, Perri P.
J Exp Clin Cancer Res. 2022 Mar 11;41(1):92. doi: 10.1186/s13046-022-02281-w.
Neuroblastoma.
Alexander F.
Urol Clin North Am. 2000 Aug;27(3):383-92, vii. doi: 10.1016/s0094-0143(05)70087-2.
Single-cell transcriptomics of human embryos identifies multiple sympathoblast lineages with potential implications for neuroblastoma origin.
Kameneva P, Artemov AV, Kastriti ME, Faure L, Olsen TK, Otte J, Erickson A, Semsch B, Andersson ER, Ratz M, Frisén J, Tischler AS, de Krijger RR, Bouderlique T, Akkuratova N, Vorontsova M, Gusev O, Fried K, Sundström E, Mei S, Kogner P, Baryawno N, Kharchenko PV, Adameyko I.
Nat Genet. 2021 May;53(5):694-706. doi: 10.1038/s41588-021-00818-x. Epub 2021 Apr 8.
Benign Neurogenic Tumors.
Farma JM, Porpiglia AS, Vo ET.
Surg Clin North Am. 2022 Aug;102(4):679-693. doi: 10.1016/j.suc.2022.04.007.
Neuroblastoma.
Castleberry RP.
Eur J Cancer. 1997 Aug;33(9):1430-7; discussion 1437-8. doi: 10.1016/s0959-8049(97)00308-0.
Neuroblastoma.
Mahapatra S, Challagundla KB.
2023 Jul 10. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan–.
Neuroblastoma.
López-Ibor B, Schwartz AD.
Pediatr Clin North Am. 1985 Jun;32(3):755-78. doi: 10.1016/s0031-3955(16)34835-0.
Eflornithine for treatment of high-risk neuroblastoma.
Jiang J, Yu Y.
Trends Pharmacol Sci. 2024 Jun;45(6):577-578. doi: 10.1016/j.tips.2024.04.005. Epub 2024 May 14.
